Author Archives: Jennifer Walker-Journey

Development of new cholesterol drug halted due to lack of efficacy

Posted: May 7, 2012 Pharmaceutical

Development on a potential blockbuster cholesterol drug has been halted by the manufacturer because the medication failed to provide benefit when added to existing standard of care in patients with coronary heart disease. A pharmaceutical product is considered a “blockbuster

Common infertility treatments may increase risk of birth defects

Posted: May 7, 2012 Pharmaceutical

Babies born with the help of common fertility treatments including in vitro fertilization (IVF) and the drug Clomid are at greater risk of birth defects, according to a new study published this month in the New England Journal of Medicine.

Canadian woman files bladder sling lawsuit

Posted: May 6, 2012 Pharmaceutical

Jane Dowall had no idea she would end up in so much pain following surgery to fix her urinary incontinence. “The pain is like a migraine headache… from knees to naval,” she told CTV. “Sometimes it’s a burning, sometimes it

Kids with type 2 diabetes have limited treatment options

Posted: May 5, 2012 Pharmaceutical

The rising number of kids being diagnosed with type 2 diabetes has created new challenges on how to manage the “adult-onset” disease in young people, according to concerns raised at a recent meeting of pediatricians in Boston.

Hundreds of Australians join artificial hip class action lawsuit

Posted: May 5, 2012 Pharmaceutical

Hundreds of Australians have joined a class action lawsuit against Johnson & Johnson after receiving artificial hips deemed to be defective. The claim is estimated to be worth about $200 million.

Public Citizen petitions FDA to ban diabetes drug Victoza due to thyroid cancer risk

Posted: May 4, 2012 Pharmaceutical

Public watchdog group Public Citizen is petitioning the U.S. Food and Drug Administration (FDA) to pull the type 2 diabetes drug Victoza off the market because it puts patients at higher risk for thyroid cancer, pancreatitis, serious allergic reactions, and

AF patients who stop using blood thinners are at greater risk for stroke

Posted: May 4, 2012 Pharmaceutical

When people with atrial fibrillation (AF) stop taking a blood thinner, their risk of having a stroke increases dramatically, according to a new study.

FDA approves new medication for erectile dysfunction

Posted: May 4, 2012 Pharmaceutical

Move over Viagra and Cialis, there’s a new erectile dysfunction drug in town, and it’s name is Stendra.

Drug overdose antidote may become available over the counter

Posted: May 4, 2012 Pharmaceutical

For the first time, the Food and Drug Administration (FDA) says it will consider allowing the over-the-counter sale of an overdose antidote as a way of curbing the rising death toll from drug overdoses each year.

Dr. Oz show investigates risks, benefits of new diet drug

Posted: May 4, 2012 Pharmaceutical

An investigational diet drug is getting media attention from celebrity doctor Dr. Oz as the “New Silver Bullet for Weight Loss,” but the Food and Drug Administration (FDA) has yet to approve the drug based on health concerns including heart